
November 20, 2026 | 18 min read
Innoterra IPO: Date, Price, Lot Size and Everything You Need to Know
Innoterra Limited operates at an unusual point in India's agri-food value chain. Rather than being a conventional dairy processor or a pure-play agritech software company, it combines farmer procurement, physical aggregation, cold-chain infrastructure, cattle nutrition and fresh-produce sourcing with technology-led supply-chain management. Its platforms connect farmers with enterprise customers across raw chilled milk, cattle nutrition, fresh fruits and staples.
The IPO comes after a period of weak reported revenue and losses followed by a return to profitability. Revenue from operations declined from ₹191.73 crore in FY24 to ₹163.47 crore in FY25, while PAT moved from a ₹28.77 crore loss to approximately ₹0.10 crore profit. For the nine months ended December 31, 2025, revenue rose sharply to ₹236.74 crore and PAT to ₹3.53 crore. The central question is whether this recovery represents a durable improvement in the economics of the underlying platforms or a business still dependent on a few large relationships and favourable operating conditions.
Business model: an integrated agri-food platform
Innoterra is the Indian operating entity of the Switzerland-headquartered Innoterra Group. Its business spans three principal verticals: raw milk procurement and supply, cattle nutrition, and FarmLink, which covers fresh fruits and staples.
The company describes its model as technology-led and asset-light. Technology is used to connect farmers with enterprise customers, capture quality and transaction data, coordinate fulfilment and improve traceability. Physical infrastructure is still essential, particularly in milk: the company operates bulk milk collection centres and bulk milk cooling units, while transportation, warehouses and certain other facilities can be operated through partners or third parties.
This creates a hybrid economic model. The company needs enough physical infrastructure to preserve product quality and maintain supply reliability, but it does not need to own the entire agricultural processing chain. The potential advantage is lower capital intensity; the corresponding risk is dependence on third-party infrastructure, farmers, logistics partners and downstream customers.
Raw milk: the anchor business
Raw milk procurement and supply remains the largest business segment. It contributed 61.96% of revenue from operations for the nine months ended December 31, 2025, compared with 57.96% in FY25, 72.29% in FY24 and 81.39% in FY23.
As of December 31, 2025, Innoterra operated 122 bulk milk collection centres across Tamil Nadu, Andhra Pradesh and Karnataka, alongside 125 bulk milk cooling units. During the nine months ended December 31, 2025, it procured 36.29 million litres of raw milk. For FY25, the company reported procurement of 24.95 million litres, all of which was supplied to customers.
The company was described in the DRHP's industry material as India's largest non-captive B2B raw milk procurement platform by procurement volume as of December 31, 2025, with procurement exceeding 100 KLPD. The distinction between 'non-captive' and captive procurement is important: Innoterra is an intermediary and supply-chain platform rather than a dairy manufacturer consuming its own milk.
MilkLane and InnoDairy: technology around a physical commodity
MilkLane is the company's raw-milk procurement platform. It sources directly from farmers through a network of bulk milk collection centres and applies quality testing and traceability protocols. The InnoDairy technology layer allows farmers to view milk quantity, quality and corresponding price at the point of delivery.
As of December 31, 2025, the company had 17,451 registered farmers and 9,275 active farmers, while the InnoDairy platform had 7,860 monthly active dairy farmers. The farmer network is therefore a core operating asset even though the company does not own the underlying agricultural production.
The model also uses quality-linked pricing. Milk procurement prices depend on market conditions as well as fat and solids-not-fat content. This gives the company a mechanism to reward quality, but it also means procurement costs can move frequently and may respond to competition from cooperatives, dairies and other aggregators.
The critical customer issue: Milky Mist concentration
The largest risk in the raw-milk business is customer concentration. Since April 2025, Milky Mist Dairy Food Limited has been the sole customer for the company's raw chilled milk business. The raw milk segment therefore has both a farmer-side supply dependency and a customer-side offtake dependency.
The arrangement provides a degree of demand visibility: Innoterra can procure milk with an identified downstream customer rather than carrying an open-ended commodity inventory position. But the concentration also means that a deterioration in the relationship, a reduction in Milky Mist's procurement requirement or a change in commercial terms could materially affect the business.
This is particularly important because the raw-milk segment still contributes the majority of revenue. The reduction in its share of group revenue over time reflects diversification, but it has not yet removed the concentration risk.
Farmer concentration and supply security
Innoterra sources its raw milk from a fragmented farmer network concentrated in Tamil Nadu and Andhra Pradesh, with Karnataka also part of the current collection footprint. The company does not enter into long-term, binding and enforceable minimum-supply agreements with farmers.
Farmer attrition was reported at 18.90% as of December 31, 2025, compared with 56.96% as of March 31, 2025, 22.96% in FY24 and 21.53% in FY23. The lower latest-period attrition is encouraging, but the historical volatility shows that maintaining farmer relationships is an active operating requirement rather than a passive assumption.
Milk supply is also seasonal and sensitive to cattle health, feed economics, weather, local competition and farmer economics. A procurement platform can only grow if it can maintain both sufficient volume and consistent quality.
Quality and cold chain: where operational capability matters
Raw milk is highly perishable, making collection speed, testing and cooling critical. Innoterra's decentralised model uses bulk milk collection centres and cooling units to chill milk close to the point of procurement. The company reports a Milk Bacterial Reduction Time of approximately three hours.
Its quality-control system includes testing for aflatoxin, antibiotics and other parameters before milk enters the supply chain. The economic benefit is not only product quality; rejection, spoilage and contamination can destroy margins in a low-value, high-volume commodity business.
The company's ability to maintain quality as the network expands is therefore an important monitorable. Adding collection centres without maintaining testing, chilling and logistics standards could increase operational losses even if procurement volumes rise.
Cattle nutrition: monetising the farmer relationship
The cattle nutrition business distributes in-house formulated cattle-feed products that are manufactured by third-party contract manufacturers. This business uses the existing farmer network as a potential distribution channel, creating a cross-selling opportunity alongside milk procurement.
During the nine months ended December 31, 2025, 50.49% of active dairy farmers also purchased cattle nutrition products. The number of such farmers increased 47.33% compared with FY25. This is a useful indicator of the platform's potential to increase revenue per farmer rather than relying only on additional milk volumes.
The model is nevertheless dependent on contract manufacturing. The company relies on two contract manufacturers in Tamil Nadu and Maharashtra for its cattle nutrition product range. Capacity, quality and input-cost management at these suppliers therefore affect the economics of the vertical.
FarmLink: diversification beyond dairy
FarmLink sources and supplies fresh fruits and staples to retailers and institutional buyers. The business uses the broader farmer and supply-chain ecosystem to create an additional route to market.
For the nine months ended December 31, 2025, revenue from fresh fruits and staples was approximately ₹62.61 crore, while cattle nutrition contributed approximately ₹27.45 crore and raw milk procurement and supply approximately ₹146.67 crore.
The diversification matters because the company is not trying to build a single-product milk aggregator. Fruits and staples can potentially improve utilisation of procurement, fulfilment and customer relationships. However, fresh produce also brings additional perishability, inventory and quality risks.
Financial performance: recovery is visible, but the base is small
Revenue from operations declined from ₹199.50 crore in FY23 to ₹191.73 crore in FY24 and ₹163.47 crore in FY25. The two-year revenue CAGR was negative. PAT was a loss of ₹16.52 crore in FY23 and ₹28.77 crore in FY24 before turning marginally positive at approximately ₹0.10 crore in FY25.
The nine months ended December 31, 2025 were materially stronger, with revenue from operations of ₹236.74 crore, EBITDA of approximately negative ₹3.50 crore and PAT of ₹3.53 crore. This indicates a significant recovery in revenue and a narrowing of operating losses.
₹ crore, unless stated | FY23 | FY24 | FY25 | 9M FY26 |
|---|---|---|---|---|
Revenue from operations | 199.50 | 191.73 | 163.47 | 236.74 |
(14.68) | (26.71) | (10.43) | (3.50) | |
PAT | (16.52) | (28.77) | 0.10 | 3.53 |
Total assets | 47.12 | 21.14 | 44.35 | 58.52 |
Net worth | 25.38 | 4.13 | 15.46 | 34.86 |
Total debt | 5.28 | 9.35 | 11.59 | 3.05 |
Operating cash flow | (2.56) | (31.20) | (11.69) | (2.0) |
0.40 | -31.60 | -11.90 | -3.30 |
The key earnings-quality issue is that profitability has only recently turned positive. The FY25 PAT of approximately ₹0.10 crore is effectively break-even, while the nine-month FY26 PAT of ₹3.53 crore is positive but still modest relative to revenue. The business therefore needs to demonstrate sustained positive EBITDA, PAT and operating cash flow before its earnings profile can be considered mature.
Working capital: fast turnover, but cash flow has historically been weak
The business handles commodities that generally move through the supply chain quickly. The company reported a working-capital turnover ratio of 41.30x in FY25, substantially above the peer benchmark cited in the DRHP's industry analysis. This indicates a relatively low amount of working capital relative to revenue.
However, high turnover does not automatically mean strong cash generation. Net cash from operating activities was negative ₹11.69 crore in FY25 and negative ₹31.20 crore in FY24. The company therefore needs to demonstrate that revenue growth can increasingly convert into operating cash.
The IPO proposes ₹54.745 crore of the fresh issue for working-capital requirements. This is meaningful relative to the company's FY25 revenue and reflects the fact that scaling procurement and supply-chain activity can increase funding needs even in a fast-turning business.
Asset-light does not mean asset-free
Innoterra's model is described as asset-light because it uses partner-operated collection centres, contract manufacturing, leased or third-party logistics and other external infrastructure. This reduces upfront capital intensity compared with owning a fully integrated dairy-processing network.
At the same time, the company still needs collection centres, cooling units, technology systems, quality laboratories, working capital and logistics coordination. The proposed IPO includes ₹10.675 crore for establishing new bulk milk collection centres and/or replacing bulk milk cooling units at existing centres.
The proposed capital expenditure is relatively modest compared with the working-capital allocation. That is consistent with the business model: the next phase of growth is more dependent on increasing throughput and supporting the supply chain than on building large manufacturing plants.
Capital structure: materially improved by FY26
Total debt decreased from ₹11.59 crore in FY25 to ₹3.05 crore as of December 31, 2025, while net worth increased from ₹15.46 crore to ₹34.86 crore. Debt-to-equity was approximately 0.09x at December 31, 2025.
The balance sheet therefore appears lightly leveraged at the latest reported date. The more relevant issue is whether the business can finance its expansion without rebuilding debt or requiring repeated equity support. Because the company is still developing its profitability, internally generated cash will be important to reducing future funding dependence.
Customer and market structure
Innoterra sells into B2B channels rather than directly to mass consumers. That reduces the need for consumer-facing brand investment but increases dependence on institutional customers and their procurement decisions.
The raw milk business is the clearest example: Milky Mist is the sole raw-chilled-milk customer from April 2025. In the fruits and staples business, customers include retailers and institutional buyers. The cattle nutrition business uses the farmer network as its primary distribution ecosystem.
The economic advantage of a B2B model is potentially lower customer-acquisition cost and more predictable offtake. The disadvantage is bargaining power: a small number of large customers can negotiate on price, volume and terms, especially when the supplier is still relatively small.
Competition: scale and specialisation rather than a simple peer set
The DRHP does not identify directly comparable listed companies operating across the same combination of technology-led B2B milk procurement, cattle nutrition, fresh fruits and staples. This makes conventional P/E or margin comparison with a single peer group less meaningful.
Competition comes from several directions: dairy cooperatives and private milk aggregators for farmer procurement; direct procurement networks of dairy processors; local traders and distributors in agricultural products; and specialised agri-supply-chain platforms.
Innoterra's differentiation rests on combining farmer access, quality-controlled aggregation, digital traceability and downstream enterprise relationships. The durability of that advantage depends on farmer retention, customer relationships and the ability to operate the network at sufficient scale.
IPO structure: fresh capital plus an OFS
The DRHP proposes a book-built IPO comprising a fresh issue of up to ₹105 crore and an offer for sale of up to 70,55,315 equity shares. The shares are proposed to be listed on BSE and NSE. The face value is ₹5 per equity share.
The fresh issue is intended primarily for the operating business. Approximately ₹10.675 crore is proposed for capital expenditure relating to new bulk milk collection centres and replacement of bulk milk cooling units, while approximately ₹54.745 crore is proposed for working-capital requirements. The balance may be used for unidentified inorganic acquisitions and general corporate purposes, subject to the limits disclosed in the DRHP.
The OFS component comprises sales by existing shareholders, including Milklane Holding and Mahyco. Proceeds from the OFS will accrue to the selling shareholders rather than Innoterra.
A pre-IPO placement of up to ₹21 crore may also be considered. If completed, the fresh issue size would be reduced by the amount raised through such placement.
Key strengths
Integrated technology-led platform connecting farmers with enterprise customers across multiple agri-food categories.
Largest non-captive B2B raw milk procurement platform in India by procurement volume as of December 31, 2025, according to the DRHP's industry report.
122 bulk milk collection centres and 125 bulk milk cooling units across Tamil Nadu, Andhra Pradesh and Karnataka.
Digitally enabled farmer network with 17,451 registered farmers and 9,275 active farmers as of December 31, 2025.
Cross-selling potential through cattle nutrition, with 50.49% of active dairy farmers also purchasing cattle nutrition products in 9M FY26.
Diversification into fresh fruits and staples reduces dependence on raw milk over time.
Asset-light structure limits the need for large manufacturing capex.
Low leverage at December 31, 2025, with debt-to-equity of about 0.09x.
Return to positive PAT in FY25 followed by stronger profitability in 9M FY26.
Key risks to monitor
Customer concentration: Milky Mist has been the sole customer for raw chilled milk since April 2025.
Farmer supply risk: There are no long-term binding minimum-supply agreements with farmers.
Farmer attrition: Historical attrition has been volatile, reaching 56.96% as of March 31, 2025.
Geographic concentration: Raw milk procurement is heavily concentrated in Tamil Nadu and Andhra Pradesh, with Karnataka also part of the network.
Procurement-price volatility: Milk prices fluctuate with seasonality, supply-demand conditions, competition and milk quality.
Profitability track record: The company incurred significant losses in FY23 and FY24 and only recently returned to profitability.
Cash-flow risk: Operating cash flow remained negative in FY24 and FY25 despite reported revenue.
Perishability and quality risk: Milk and fresh produce require tight temperature, quality and logistics controls.
Contract-manufacturing dependence: Cattle nutrition products rely on two contract manufacturers.
Competition: Cooperatives, private dairies, local aggregators and other agri-supply-chain businesses compete for farmers and customers.
Execution risk: Expansion of collection centres and working capital must translate into sustainable incremental throughput and margins.
Inorganic-acquisition risk: A portion of IPO proceeds may be used for acquisitions that were unidentified at the DRHP stage.
What to watch after the IPO
Raw milk procurement volumes in KLPD and litres procured
Revenue share and profitability of the raw milk segment
Milky Mist concentration and development of alternative raw-milk customers
Active farmer count, farmer attrition and farmer retention
Milk quality, rejection rates and cold-chain performance
Revenue per active farmer and cattle-nutrition cross-sell penetration
FarmLink growth in fresh fruits and staples
Gross margin and EBITDA margin by business vertical
Operating cash flow relative to EBITDA and PAT
Working-capital days and working-capital turnover
Utilisation and economics of bulk milk collection/cooling centres
Debt levels after expansion and internal cash generation
Returns generated from any inorganic acquisitions
The bigger picture
Innoterra is best understood as an agri-supply-chain company rather than simply a dairy business. Its core proposition is to organise fragmented agricultural supply, apply technology and quality controls, and connect farmers with larger enterprise buyers. That can create value without requiring the company to own farms or large processing plants.
The financial record, however, is still in transition. Revenue declined for two consecutive years through FY25, the company recorded substantial losses in FY23 and FY24, and operating cash flow remained negative. The improvement visible in 9M FY26 is therefore important, but it needs to be sustained across a full financial cycle.
The most important tension is between platform diversification and concentration. Innoterra has expanded beyond raw milk into cattle nutrition, fruits and staples, yet the milk business remains the largest segment and depends heavily on one customer. At the same time, the company relies on a fragmented farmer network without binding long-term supply commitments.
The IPO provides relatively modest fixed-asset capital but substantial working-capital funding. That fits the asset-light model: the next stage of growth depends on increasing throughput through the existing network, adding collection infrastructure selectively, monetising the farmer ecosystem across products and improving operating leverage.
The key analytical test is therefore not simply whether revenue can grow. It is whether Innoterra can turn a growing farmer and customer network into consistently positive EBITDA, PAT and operating cash flow while reducing its dependence on any single customer, geography or agricultural commodity.
Disclaimer: This blog is only for educational and informational purposes and does not constitute investment advice. Please consult your financial advisor before taking any investment decisions.
